AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ProPhase Labs, Inc. Director's Dealing 2019

Apr 4, 2019

34999_dirs_2019-04-04_1233ecb3-f847-4ca6-a8ba-5f0a500092e5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ProPhase Labs, Inc. (PRPH)
CIK: 0000868278
Period of Report: 2019-04-03

Reporting Person: GLECKEL LOUIS MD (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-04-03	Common Stock, par value $0.0005	A	3571	$3.15	Acquired	93863	Direct

Footnotes

F1: These shares of common stock were issued pursuant to the terms of the 2010 Directors' Equity Compensation Plan, as amended, for director fees payable to non-employee directors.